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EFFECT OF Ficus deltoidea LEAVES ON GLUCOSE AND
GLYCOGEN METABOLISM IN LIVER OF NORMAL AND
STREPTOZOTOCIN-INDUCED DIABETIC RATS
ABSTRACT
Ficus deltoidea from the Moraceae family is commonly called "mas cotek" by the
Malays. The Malay folklor e medicines believed that consuming a decoction of the
vascular bundl e of Ficus deltoidea led to a lowering of the blood glucose level of
diabetic patients. The present study was designed primarily to evaluate the antidiabetic
activity of Ficus deltoidea leaves on in-vivo and in-vitro models . Phytochemical
examination of the plant by using simple qualitative screening methods showed that the
aqueous and ethanolic extracts of Ficus deltoidea leaves contained saponins, flavonoids
and tannins. The extracts also showed high inhibitory activity on a-glucosidase. To
evaluate the effects of Ficus deltoidea leaves extracts on the hepatic activities of key
glucose metabolic enzymes, non-diabetic and streptozotocin (STZ)-induced diabetic rats
were treated with the extracts (200 mg/kg) for 2 weeks. Diabetes was induced in 1
month old rats by single intravenous injection of STZ at a dose of 65 mg/kg body
weight. After a week , they were checked for fasting blood glucose concentrations to
confirm the status of diabetes. The blood glucose concentrations were measured for 2
weeks upon the administration of Ficus deltoidea extract. A significant increase was
observed in fasting blood glucose level in untreated diabetic rats. Diabetic rats also
showed a significant decrease in the activities of hepatic hexokinase (HK), glucokinase
(OK) , phosphofructokinase (PFK), glucose-6-phosphate dehydrogenase (06PDH) and
glycogen content. Conversely, a significant increase in the activity of fructose-1 ,6-
bisphosphatase (FBPase) was observed in untreated diabetic rats. However , after 14 days
treatment with the plant extracts, the activities of HK (p < 0.01) , OK (p< 0.05) , PFK (p <
0.05), 06PDH (p < 0.05) and the levels of hepatic glycogen (p < 0.05) were found to
significantly increase while the activity of FBPase (p < 0.05) was significantly decreased
at the end of the experiment. The findings suggest that Ficus deltoidea exert its
antidiabetic effect by inhibiting a-glucosidase, increasing glycolysis and decreasing
gluconeogenesis.
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CHAPTER 1
INTRODUCTION
1.1 General overview
Diabetes mellitus is a syndrome, which affects more and more people in all countries
over the world. It is the fourth or fifth leading cause of death in the world (Andrew &
Clifford , 2001). The incidence of diabetes mellitus is on the rise all over the world ,
especially in Asia . The World Health Organization (WHO) in 1994 estimated 46.9
million people with diabetes in Asia. They forecast that the number would rise to 126.2
million by the year 2010 and this increase will affect both industrialized and developing
countries.
Two major types of diabetes are recognized clinically by WHO namely , insulin-
dependent diabetes mellitus (lDDM) or type I and non-insulin dependent diabetes
mellitus (NIDDM) or type II. Type I develops due to the autoimmune destruction of the
insulin -producing ~-cells of the pancreas while diabetes mellitus type II arises from a
heterogeneous etiology, with secondary effect from environmental influences . Type I is
conventionally treated with exogenous insulin . Exogenous therapy is required to prevent
ketosis and to reduce the hyperglucagonemia and the elevated blood glucose level. Type
II is treated with oral hypoglycemic agents such as sulphonylureas and biguanides (Felig
et al., 1995; Rosak , 2002). Oral hypoglycemic agents are used to stimulate the
pancreatic ~-cells to secrete insulin and/or increase the sensitivity of peripheral insulin
